Use of Flavored E-Cigarettes Among Adolescents, Young Adults, and Older Adults: Findings From the Population Assessment for Tobacco and Health Study

Public Health Reports

Volumn 134, Issue 3, 2019, Pages 282-292

  Soneji, Samir S ^a,b   Knutzen, Kristin E ^b   Villanti, Andrea C ^c  

^a NORRIS COTTON CANCER CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

electronic cigarettes; flavors; regulation; tobacco

Indexed keywords

MENTHOL; FLAVORING AGENT;

ADOLESCENT; ADOLESCENT SMOKING; ADULT; AGE DISTRIBUTION; ARTICLE; CANDY; CIGARETTE SMOKING; FEMALE; FLAVOR; FRUIT; HUMAN; MALE; PRIORITY JOURNAL; TOBACCO; VAPING; YOUNG ADULT; CHILD; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; ETHNOLOGY; PSYCHOLOGY;

ADOLESCENT; ADULT; CHILD; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; FLAVORING AGENTS; HUMANS; MALE; TOBACCO PRODUCTS; VAPING; YOUNG ADULT;

EID: 85063010269     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/0033354919830967     Document Type: Article

References (49)

1. US Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2016.
2. Murthy VH. E-cigarette use among youth and young adults: a major public health concern. JAMA Pediatr. 2017;171(3):209–210. doi:10.1001/jamapediatrics.2016.4662
3. Villanti AC, Johnson AL, Ambrose BK. Flavored tobacco product use in youth and adults: findings from the first wave of the PATH Study (2013-2014). Am J Prev Med. 2017;53(2):139–151. doi:10.1016/j.amepre.2017.01.026
4. Arrazola RA, Dube SR, King B. Tobacco product use among middle and high school students—United States, 2011 and 2012 [published erratum appears in MMWR Morb Mortal Wkly Rep. 2013;62(46):940]. MMWR Morb Mortal Wkly Rep. 2013;62(45):893–897.
5. Cullen KA. Notes from the field: use of electronic cigarettes and any tobacco product among middle and high school students—United States, 2011-2018. MMWR Morb Mortal Wkly Rep. 2018;67(45):1276–1277.
6. Ambrose BK, Day HR, Rostron B. Flavored tobacco product use among US youth aged 12-17 years, 2013-2014. JAMA. 2015;314(17):1871–1873. doi:10.1001/jama.2015.13802
7. Pepper JK, Ribisl KM, Brewer NT. Adolescents’ interest in trying flavoured e-cigarettes. Tob Control. 2016;25(suppl 2):ii62–ii66. doi:10.1136/tobaccocontrol-2016-053174
8. Ford A, MacKintosh AM, Bauld L, Moodie C, Hastings G. Adolescents’ responses to the promotion and flavouring of e-cigarettes. Int J Public Health. 2016;61(2):215–224. doi:10.1007/s00038-015-0769-5
9. Huang LL, Baker HM, Meernik C, Ranney LM, Richardson A, Goldstein AO. Impact of non-menthol flavours in tobacco products on perceptions and use among youth, young adults and adults: a systematic review. Tob Control. 2017;26(6):709–719. doi:10.1136/tobaccocontrol-20160053196
10. Welz C, Canis M, Schwenk-Zieger S. Cytotoxic and genotoxic effects of electronic cigarette liquids on human mucosal tissue cultures of the oropharynx. J Environ Pathol Toxicol Oncol. 2016;35(4):343–354. doi:10.1615/JEnvironPatholToxicolOncol.2016016652
11. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol. 2012;34(4):529–537. doi:10.1016/j.reprotox.2012.08.001
12. Kosmider L, Sobczak A, Prokopowicz A. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax. 2016;71(4):376–377. doi:10.1136/thoraxjni-2015-207895
13. Clapp PW, Pawlak EA, Lackey JT. Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L278–L292. doi:10.1152/ajplung.00452.2016
14. Gerloff J, Sundar IK, Freter R. Inflammatory response and barrier dysfunction by different e-cigarette flavoring chemicals identified by gas chromatography-mass spectrometry in e-liquids and e-vapors on human lung epithelial cells and fibroblasts. Appl In Vitro Toxicol. 2017;3(1):28–40. doi:10.1089/aivt.2016.0030
15. Farsalinos KE, Kistler KA, Gillman G, Voudris V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob Res. 2015;17(2):168–174. doi:10.1093/ntr/ntu176
16. National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. Washington, DC: National Academies Press; 2018.
17. Zhu SH, Sun JY, Bonnevie E. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control. 2014;23(suppl 3):iii3–iii9. doi:10.1136/tobaccocontrol-2014-051670
18. FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death [news release]. Silver Spring, MD: US Food and Drug Administration; 2017. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm568923.htm. Accessed January 8, 2019.
19. Harrell MB, Weaver SR, Loukas A. Flavored e-cigarette use: characterizing youth, young adult, and adult users. Prev Med Rep. 2016;5:33–40. doi:10.1016/j.pmedr.2016.11.001
20. Berg CJ. Preferred flavors and reasons for e-cigarette use and discontinued use among never, current, and former smokers. Int J Public Health. 2016;61(2):225–236. doi:10.1007/s00038-015-0764-x
21. Hyland A, Ambrose BK, Conway KP. Design and methods of the Population Assessment of Tobacco and Health (PATH) Study. Tob Control. 2017;26(4):371–378. doi:10.1136/tobaccocontrol-2016-052934
22. National Addiction & HIV Data Archive Program (NAHDAP). Population Assessment of Tobacco and Health (PATH) Study [United States] restricted-use files (ICPSR 36231). 2018. https://www.icpsr.umich.edu/icpsrweb/NAHDAP/studies/36231. Accessed January 20, 2018.
23. Kasza KA, Ambrose BK, Conway KP. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med. 2017;376(4):342–353. doi:10.1056/NEJMsa1607538
24. Amato MS, Boyle RG, Levy D. How to define e-cigarette prevalence? Finding clues in the use of frequency distribution. Tob Control. 2016;25(e1):e24–e29. doi:10.1136/tobaccocontrol-2015-052236
25. Digard H, Errington G, Richter A, McAdam K. Patterns and behaviors of snus consumption in Sweden. Nicotine Tob Res. 2009;11(10):1175–1181. doi:10.1093/ntr/ntp118
26. R Foundation. The Comprehensive R Archive Network. 2018. https://cran.r-project.org. Accessed January 20, 2018.
27. Morean ME, Butler ER, Bold KW. Preferring more e-cigarette flavors is associated with e-cigarette use frequency among adolescents but not adults. PLoS One. 2018;13(1):e0189015. doi:10.1371/journal.pone.0189015
28. Shiffman S, Sembower MA, Pillitteri JL, Gerlach KK, Gitchell JG. The impact of flavor descriptors on nonsmoking teens’ and adult smokers’ interest in electronic cigarettes. Nicotine Tob Res. 2015;17(10):1255–1262. doi:10.1093/ntr/ntu333
29. Soule EK, Lopez AA, Guy MC, Cobb CO. Reasons for using flavored liquids among electronic cigarette users: a concept mapping study. Drug Alcohol Depend. 2016;166:168–176. doi:10.1016/j.drugalcdep.2016.07.007
30. Audrain-McGovern J, Strasser AA, Wileyto EP. The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers. Drug Alcohol Depend. 2016;166:263–267. doi:10.1016/j.drugalcdep.2016.06.030
31. Goldenson NI, Kirkpatrick MG, Barrington-Trimis JL. Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: application of a novel methodology. Drug Alcohol Depend. 2016;168:176–180. doi:10.1016/j.drugalcdep.2016.09.014
32. Allen JG, Flanigan SS, LeBlanc M. Flavoring chemicals in e-cigarettes: diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect. 2016;124(6):733–739. doi:10.1289/ehp.151085
33. Khlystov A, Samburova V. Flavoring compounds dominate toxic aldehyde production during e-cigarette vaping. Environ Sci Technol. 2016;50(23):13080–13085. doi:10.1012/acs.est.6b05145
34. Lee MS, LeBouf RF, Son YS, Koutrakis P, Christiani DC. Nicotine, aerosol particles, carbonyls and volatile organic compounds in tobacco- and menthol-flavored e-cigarettes. Environ Health. 2017;16(1):42. doi:10.1186/s12940-017-0249-x
35. Leslie LJ, Vasanthi Bathrinarayanan P, Jackson P. A comparative study of electronic cigarette vapor extracts on airway-related cell lines in vitro. Inhal Toxicol. 2017;29(3):126–136. doi:10.1080/08958378.2017.1318193
36. Sherwood CL, Boitano S. Airway epithelial cell exposure to distinct e-cigarette liquid flavorings reveals toxicity thresholds and activation of CFTR by the chocolate flavoring 2,5-dimethypyrazine. Respir Res. 2016;17(1):57. doi:10.1186/s12931-016-0369-9
37. Gottlieb S. Protecting American families: comprehensive approach to nicotine and tobacco [speech]. White Oak, MD: US Food and Drug Administration, Commissioner; 2017. https://www.fda.gov/newsevents/speeches/ucm569024.htm. Accessed January 8, 2019.
38. Public Health Law Center. Regulating flavored tobacco products. 2017. https://www.publichealthlawcenter.org/sites/default/files/resources/Regulating-Flavored-Tobacco-Products-2017.pdf. Accessed January 8, 2019.
39. Carpenter CM, Wayne GF, Pauly JL, Koh HK, Connolly GN. New cigarette brands with flavors that appeal to youth: tobacco marketing strategies. Health Aff (Millwood). 2005;24(6):1601–1610. doi:10.1377/hlthaff.24.6.1601
40. Muscat JE, Chen G, Knipe A, Stellman SD, Lazarus P, Richie JP, Jr. Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation. Cancer Epidemiol Biomarkers Prev. 2009;18(1):35–41. doi:10.1158/1055-9965.EPI-08-0744
41. Keeler C, Max W, Yerger V, Yao T, Ong MK, Sung HY. The association of menthol cigarette use with quit attempts, successful cessation, and intention to quit across racial/ethnic groups in the United States. Nicotine Tob Res. 2017;19(12):1450–1464. doi:10.1093/ntr/ntw215
42. Benowitz NL, Samet JM. The threat of menthol cigarettes to U.S. public health. N Engl J Med. 2011;364(23):2179–2181. doi:10.1056/NEJMo1103610
43. Tobacco Products Scientific Advisory Committee. Preliminary Scientific Evaluation of the Possible Public Health Effects of Menthol Versus Nonmenthol Cigarettes. Rockville, MD: Center for Tobacco Products, US Food and Drug Administration; 2011.
44. Villanti AC, Collins LK, Niaura RS, Gagosian SY, Abrams DB. Menthol cigarettes and the public health standard: a systematic review. BMC Public Health. 2017;17(1):983. doi:10.1186/s12889-017-4987-z
45. Reidel B, Radicioni G, Clapp PW. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med. 2017;197(4):492–501. doi:10.1164/rccm.201708-1590OC
46. Muthumalage T, Prinz M, Ansah KO, Gerloff J, Sundar IK, Rahman I. Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine. Front Physiol. 2018;8:1130. doi:10.3389/fphys.2017.01130
47. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127–133. doi:10.1093/ntr/ntu200
48. Zhuang YL, Cummins SE, Sun JY, Zhu SH. Long-term e-cigarette use and smoking cessation: a longitudinal study with US population. Tob Control. 2016;25(suppl 1):i90–i95. doi:10.1136/tobaccocontrol-2016-053096
49. Zhu SH, Zhuang YL, Wong S, Cummins SE, Tedeschi GJ. E-cigarette use and associated changes in population smoking cessation: evidence from US Current Population Surveys. BMJ. 2017;358:j3262. doi:10.1136/bj.3262